CERVO Therapeutics AB

ABIn liquidation

Org 5593144891Research and experimental development on biotechnology · NACE 7211Est. 20210 employees

Overview Financials People & ownership Related companies

CERVO Therapeutics AB is a Swedish AB, operating in the Bioteknisk forskning och utveckling sector. Incorporated in 2021, the company has 0 employees.

Revenue 2024

—

EBITDA margin

—

-156% vs 2023

Equity ratio

40.3%

Financial strength

Net profit 2024

SEK -3K

-172% vs 2023

EBITDA — year on year

SEK millions

Key figures

Annual report 2024

Revenue	—	—
EBITDA	SEK -4K	-156%
Net profit	SEK -3K	-172%
Total assets	SEK 44K	-3%
Equity	SEK 18K	-16%
Employees	0	—

Contact

Address

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of CERVO Therapeutics AB?

CERVO Therapeutics AB is registered with Bolagsverket / SCB under Org 5593144891.

Who is the CEO of CERVO Therapeutics AB?

Jonny Lennart Greinsmark is Liquidator of CERVO Therapeutics AB, in role since 2024.

Who is the chairman of CERVO Therapeutics AB?

Mathilde Annabelle Cheray chairs the board of CERVO Therapeutics AB, in role since 2022.

CERVO Therapeutics AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on CERVO Therapeutics AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on CERVO Therapeutics AB